ROBERT F. BARTLETT - 20 Aug 2024 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
CEO and President, Director
Signature
/s/ Robert Bartlett
Issuer symbol
PURE
Transactions as of
20 Aug 2024
Net transactions value
$0
Form type
4
Filing time
22 Aug 2024, 17:58:36 UTC
Previous filing
03 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +155,000 $0.000000 155,000 20 Aug 2024 Common Stock 155,000 $0.0700 Direct F1
transaction PURE Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 20 Aug 2024 Common Stock 500,000 $0.0700 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025.
F2 The option shares are fully vested as of the date of grant.